Andrew Oakley

Andrew Oakley

Direktor/Vorstandsmitglied bei
UNION Therapeutics A/S

Vermögen: 199 311 $ am 31.07.2026

63 Jahre
Health Technology
Consumer Services
Commercial Services

Profil

Andrew J.
Oakley
is currently Director at Virometix AG, Executive Director at Novaremed AG, Director at Brian Oakley Ltd. since 2003, Director at Oakley Coachbuilders Ltd. since 2014, Director at UNION Therapeutics A, Director at Metys Pharmaceuticals AG, Independent Director at Tribeca Strategic Acquisition Corp.
starting 2026, and Member of The Institute of Chartered Accountants in Australia since 1987.
Former roles include Non-Executive Chairman at Onconetix, Inc. from 2025 to 2026, CFO, Secretary & Executive Director at Vectura Group Ltd. from 2015 to 2016, Chief Financial Officer, Secretary & Director at Vectura GmbH, Chief Financial Officer & Executive Vice President at Actelion Ltd., Chief Financial Officer & Executive Vice President at Nxera Pharma Co., Ltd. from 2017 to 2018, Chief Financial Officer at NovImmune SA in 2014, Member-Supervisory Board at Ventaleon GmbH, Chief Financial Officer & Executive Vice President at Actelion Pharmaceuticals Ltd. from 2003 to 2013, and Chief Financial Officer & Executive Vice President at Autolus Therapeutics Plc from 2018 to 2023.
Education includes undergraduate studies at Macquarie University and an MBA from London Business School.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
0.43%
28.05.2026 20’000 ( 0.43% ) 199 300 $ 31.07.2026
13.03.2026 13 ( 0% ) 11 $ 31.07.2026

Aktive Positionen von Andrew Oakley

UnternehmenPositionBeginn
The Institute of Chartered Accountants in Australia
Corporate Officer/Principal 21.05.2010
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied 01.04.2003
Direktor/Vorstandsmitglied 23.06.2014
Direktor/Vorstandsmitglied -

Ehemalige bekannte Positionen von Andrew Oakley

UnternehmenPositionEnde
ONCONETIX, INC. Vorsitzender 20.04.2026
AUTOLUS THERAPEUTICS PLC Finanzdirektor/CFO 01.01.2023
░░░░░ ░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Andrew Oakley im Detail an

Ausbildung von Andrew Oakley

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

63

Beziehungen ersten Grades

18

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen18

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Commercial Services

The Institute of Chartered Accountants in Australia

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Commercial Services

Health Technology

  1. Börse
  2. Insiders
  3. Andrew Oakley